TMB Fee Base

Product Description

TMB Fee Base
Catalog number: B2016281
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 5 g
Molecular Weight or Concentration: 240.35 g/mol
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: 3,3’,5,5’-Tetramethylbenzidine, free base
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y, Zhou C. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy Acta Pharm Sin B. 2021 Oct;11(10):2983-2994.
2: León-Castillo A, Britton H, McConechy MK, McAlpine JN, Nout R, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT, Bosse T, Church DN, Gilks CB. Interpretation of somatic POLE mutations in endometrial carcinoma J Pathol. 2020 Mar;250(3):323-335.
3: Fulton-Ward T, Middleton G. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review Ann Oncol. 2023 Dec;34(12):1113-1130.
4: Sun R, Li Z, Bishop TC. TMB Library of Nucleosome Simulations J Chem Inf Model. 2019 Oct 28;59(10):4289-4299.
5: Nutiu R, Li Y. Tripartite molecular beacons Nucleic Acids Res. 2002 Sep 15;30(18):e94.
6: Moog S, Lamartina L, Bani MA, Al Ghuzlan A, Friboulet L, Italiano A, Lacroix L, Postel Vinay S, Tselikas L, Deschamps F, Bonnet B, Pani F, Baudin E, Hadoux J. Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports Thyroid. 2023 Nov;33(11):1368-1373.
7: Feng D, Wang J, Shi X, Li D, Wei W, Han P. Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients Eur J Med Res. 2023 May 13;28(1):172.
8: Pai SG, Carneiro BA, Chae YK, Costa RL, Kalyan A, Shah HA, Helenowski I, Rademaker AW, Mahalingam D, Giles FJ. Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer J Gastrointest Oncol. 2017 Oct;8(5):858-866.
9: Yan H, Song L, Li Y, Xu Q, Guo W, Lin S, Jiang W, Wang Z, Deng L, Huang Z, Qin H, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Yu J, Dong X, Gong Q, Deng J, Chen X, Wang J, Zhang G, Yang N, Zhang Y, Zeng L. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China Cancer Immunol Immunother. 2024 Mar 7;73(4):74.
10: Lin C, Du Y, Wang S, Wang L, Song Y. Glucose oxidase@Cu-hemin metal-organic framework for colorimetric analysis of glucose Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111511.

Products Related to TMB Fee Base can be found at Substrates